Watchlist Price Alert

XOMA Corporation (XOMA)

NASDAQ: XOMA · Real-Time Price · USD

25.45

0.30 (1.19%)

At close: May 29, 2025, 3:59 PM

25.50

0.20%

After-hours: May 29, 2025, 04:02 PM EDT

1.19% (1D)

Bid	24.2
Market Cap	304.56M
Revenue (ttm)	36.54M
Net Income (ttm)	-2.86M
EPS (ttm)	-0.73
PE Ratio (ttm)	-34.86
Forward PE	416.67
Analyst	Buy

Ask	27
Volume	29,175
Avg. Volume (20D)	33,478
Open	25.77
Previous Close	25.15
Day's Range	25.21 - 26.79
52-Week Range	18.35 - 35.00
Beta	0.90

About XOMA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol XOMA

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for XOMA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

5 months ago

-3.05%

XOMA Royalty shares are trading higher after the c... Unlock content with Pro Subscription

News

2 weeks ago · zacks.com

XOMA Royalty (XOMA) Tops Q1 Earnings and Revenue Estimates

XOMA Royalty (XOMA) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.26 per share. This compares to loss of $0.86 per share a year ago.

1 month ago · accessnewswire.com

BioInvent Receives Milestone Payment as Takeda moves mezagitamab into Phase 3

LUND, SWEDEN / ACCESS Newswire / April 8, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-clas...

1 month ago · seekingalpha.com

XOMA Royalty Corporation's Preferreds Still Offer Attractive Yields With A Biotech Twist

XOMA aggregates future biotech royalties and milestone rights for stable, diversified revenue streams. However, I believe its preferred shares (under tickers XOMAO and XOMAP) offer attractive yields w...